PT2095815E - Formulações farmacêuticas contendo clopidogrel - Google Patents

Formulações farmacêuticas contendo clopidogrel Download PDF

Info

Publication number
PT2095815E
PT2095815E PT08380057T PT08380057T PT2095815E PT 2095815 E PT2095815 E PT 2095815E PT 08380057 T PT08380057 T PT 08380057T PT 08380057 T PT08380057 T PT 08380057T PT 2095815 E PT2095815 E PT 2095815E
Authority
PT
Portugal
Prior art keywords
pharmaceutical formulations
formulations containing
containing clopidogrel
composition
pharmaceutical formulation
Prior art date
Application number
PT08380057T
Other languages
English (en)
Inventor
Ignacio Diez Martin
Carmen Ubeda Perez
Maria Aranzazu Arino Ros
Original Assignee
Lesvi Laboratorios Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lesvi Laboratorios Sl filed Critical Lesvi Laboratorios Sl
Publication of PT2095815E publication Critical patent/PT2095815E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
PT08380057T 2008-02-26 2008-02-26 Formulações farmacêuticas contendo clopidogrel PT2095815E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08380057A EP2095815B1 (en) 2008-02-26 2008-02-26 Pharmaceutical formulations containing clopidogrel

Publications (1)

Publication Number Publication Date
PT2095815E true PT2095815E (pt) 2012-02-03

Family

ID=39561443

Family Applications (1)

Application Number Title Priority Date Filing Date
PT08380057T PT2095815E (pt) 2008-02-26 2008-02-26 Formulações farmacêuticas contendo clopidogrel

Country Status (6)

Country Link
US (1) US20090214646A1 (pt)
EP (1) EP2095815B1 (pt)
AT (1) ATE530172T1 (pt)
ES (1) ES2376057T3 (pt)
HR (1) HRP20120072T1 (pt)
PT (1) PT2095815E (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013502384A (ja) * 2009-08-18 2013-01-24 カーギル インコーポレイテッド イソマルトの圧縮方法
CN103181885A (zh) * 2011-12-30 2013-07-03 北京韩美药品有限公司 氯吡格雷的固体制剂及制备方法
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
EP2275141A1 (en) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
GB2393181A (en) 2002-09-19 2004-03-24 Cipla Ltd Amorphous clopidogrel
GB0325603D0 (en) * 2003-11-03 2003-12-10 Sandoz Ag Organic compounds
WO2005070464A2 (en) 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
EA010831B1 (ru) 2004-04-20 2008-12-30 Санофи-Авентис ПОЛИМОРФНАЯ ФОРМА D ГИДРОБРОМИДА МЕТИЛ-(+)-(S)-α-(2-ХЛОРФЕНИЛ)-6,7-ДИГИДРОТИЕНО[3,2-C]ПИРИДИН-5(4H)-АЦЕТАТА
KR20070009851A (ko) 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물
KR20070044323A (ko) 2005-10-24 2007-04-27 에스케이케미칼주식회사 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제
IS2385B (is) 2006-02-10 2008-07-15 Actavis Group Hf. Klópidógrel bísúlfat lyfjasamsetningar
ES2342965T5 (es) 2006-04-13 2013-04-03 Acino Pharma Ag Gliceridos parciales como lubricantes para composiciones farmacéuticas que contienen derviados de tieno(3,2-c)piridina

Also Published As

Publication number Publication date
HRP20120072T1 (hr) 2012-02-29
EP2095815B1 (en) 2011-10-26
ATE530172T1 (de) 2011-11-15
US20090214646A1 (en) 2009-08-27
EP2095815A1 (en) 2009-09-02
ES2376057T3 (es) 2012-03-08

Similar Documents

Publication Publication Date Title
IL233677A (en) Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
ZA201101523B (en) Linaclotide-containing formulations for oral administration
HK1128471A1 (en) Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
WO2012021715A3 (en) Stable formulations of linaclotide
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
MY177741A (en) Pharmaceutical compositions compring 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one-lactate monohydrate.
HK1180949A1 (en) Long lasting drug formulations
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
EP2142549A4 (en) ADENOSINE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES THEREOF CONTAINING THEM AS AN ACTIVE SUBSTANCE
WO2011019326A3 (en) Solubility and stability enchancing pharmaceutical formulation
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
EP1895996A4 (en) FORMULATION FOR THE PROPHYLAXIS OF DISEASES OF THE MOUTH VALVE
IL201418A0 (en) Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
IL208325A0 (en) Stabilizing lipis compositions for oral pharmaceutical agents
PT2095815E (pt) Formulações farmacêuticas contendo clopidogrel
HK1098059A1 (en) Composition comprising itraconazole for oral administration
WO2010077669A3 (en) Palonosetron formulation
HK1122731A1 (en) Prolonged release formulation of active pharmaceutical ingredients
WO2009121946A3 (en) Process for the preparation of optically enriched clopidogrel
HK1092734A1 (en) Oral formulation for twice-daily administration
EP1994003A4 (en) PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEY
WO2011002424A3 (en) Solubility and stability enchancing pharmaceutical formulation comprising ezetimibe and simvastatin
ZA200806439B (en) Stable dosage formulations of imidazolylalkyl-pyridines